- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01068691
Arterial Properties of Thoracic Aorta Disease (ao_diss)
Blood Pressure Control and Arterial Properties After Surgical Treatment of Type A Thoracic Aortic Dissection or Haematoma
A dissecting or intramural haematoma of the thoracic aorta (AH) is a haemorrhage that dissects the aortic wall. An entry point is detected at an intimal tear, ulcer or plaque rupture via imaging in almost 50% of cases. AH occurs in older patients than those with AD and develops on atheromatous lesions with parietal ulcers, most often in cases of poorly managed, pre-existing hypertension (HTN). Type A AHs, which affect the ascending aorta, frequently progress towards an AD with a high risk of mortality, and represent a surgical indication.
Patients who have presented AD or AH, whether they have been operated or not, must undergo prolonged monitoring. This involves both clinical and radiological checks to ensure that blood pressure is properly monitored, that the parietal lesions have receded and that there are no complications.
HTN is a recognized risk factor for the onset of AD and systolic blood pressure must be brought down to between 100 and 120 mmHg perioperatively. Furthermore, HTN is also a risk factor for the rupture of unoperated type B AD. Despite this, only two studies have looked at BP management in AD patients. The first, carried out among chronic type A or B AD patients revealed that closer monitoring of blood pressure levels at home led to a better long-term prognosis. Another study revealed a 60% prevalence of non-managed clinical HTN among 40 chronic AD patients.
Whilst frequent, regular aortic wall monitoring via imaging methods (CT or MRI) is recommended after thoracic AD surgery, there is no precise recommendation as to the method of BP monitoring in very high-risk patients. A BP level of 135/80 mmHg has been suggested as a maximum limit for patients having been operated for AD. In order to achieve this, antihypertensives of several therapeutic classes must be used, with beta-blockers as a priority. The same can be said for AH, as it has been demonstrated that the absence of beta-blocker treatment is a predictive factor for poor progress.
Increased aortic stiffness can cause increased systolic blood pressure and is recognized as an independent cardiovascular risk factor. This stiffness can be detected by measuring the carotid-to-femoral pulse wave velocity (PWV). No study has as yet focused on assessing aortic stiffness in patients who have undergone AD or AH surgery.
Obstructive sleep apnea syndrome (OSAS) in thoracic AD patients is highly prevalent, and respiratory events that occur are more severe. This has prompted some to suggest that systematic detection of OSAS after AD should be carried out. No findings have yet been published about patients who have undergone AH surgery.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Main objective:
- To evaluate the level of blood pressure control using ambulatory blood pressure monitoring in patients who have undergone surgery for a type A thoracic AD or AH.
Secondary objectives:
- To study aortic stiffness within this patient population and determine its predictive parameters.
- To determine the prevalence of OSAS among this patient population and study the relationship between respiratory data and blood pressure values.
- To determine the respective roles of blood pressure level, aortic stiffness, and respiratory and biological parameters upon the postoperative aortic diameters of patients who have undergone surgery for type A thoracic AD or AH.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: BAGUET Jean-Philippe, MD, PhD
- Phone Number: (33+) 476768480
- Email: JPBaguet@chu-grenoble.fr
Study Locations
-
-
-
Grenoble, France
- Recruiting
- University Hospital
-
Principal Investigator:
- BAGUET JB Jean-Philippe, Pr
-
Sub-Investigator:
- CHAVANON OC Olivier, Pr
-
Sub-Investigator:
- PEPIN JP Jean-Louis, Pr
-
Sub-Investigator:
- THONY FT Frederic, Dr
-
Sub-Investigator:
- BARONE ROCHETTE GB Gilles, Dr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Male or female patients aged 18 or over who:
- benefit from the French social security system
- will be monitored as outpatients
- have given their written consent to participate in this study
- have been operated over 6 months ago for a type A thoracic AD or AH at Grenoble University Hospital in the period from 1 January 1990 to 30 June 2007
- are able to travel to Grenoble University Hospital
Exclusion Criteria:
- Bedridden or reduced mobility patients.
- Patients whose physical or psychological condition could affect their informed consent and compliance with the requirements of the protocol.
- Adult patients protected by the law (article L1121-8 of the French Public Health Code).
- Individuals serving a prison sentence (article L1121-8 of the French Public Health Code).
- Women who are pregnant, have recently given birth or are breastfeeding.
- Patients in the terminal phase of a serious illness.
- Individuals serving a prison sentence as a result of a legal or administrative ruling, or individuals receiving legal protection.
- Children.
- Patients taking part in another study.
- Individual who is not part of the social security system or who does not benefit from it.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Ambulatory blood pressure monitoring
Time Frame: the same day as inclusion
|
the same day as inclusion
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Aortic stiffness, Aortic diameters
Time Frame: the same day as inclusion
|
the same day as inclusion
|
polysomnography to research Sleep apnea
Time Frame: within 2 months
|
within 2 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: jean-philippe baguet, Pr, University Hospital, Grenoble
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 706
- 2007-A01422-51 (Registry Identifier: AFSSAPS)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Pressure
-
DongGuk UniversityActive, not recruitingHypertension | Blood Pressure | Ambulatory Blood Pressure | Home Blood Pressure MeasurementKorea, Republic of
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
University of JordanCompletedBlood Pressure | Heart Rate | Airway PressureJordan
-
Istituto Auxologico ItalianoRecruitingArterial Hypertension | Ambulatory Blood Pressure Monitoring | Blood Pressure Determination | Home Blood Pressure MonitoringItaly
-
RadiRad Co., Ltd.Hualien Tzu Chi General HospitalNot yet recruitingBlood Pressure
-
Riphah International UniversityRecruiting
-
GE HealthcareNot yet recruiting
-
Guangdong Provincial People's HospitalRecruiting
-
Guangdong Provincial People's HospitalRecruiting
Clinical Trials on Ambulatory blood pressure monitoring (to evaluate the level of blood pressure)
-
University of MichiganCompletedHypertensionUnited States
-
University of VigoUniversity of California, Los Angeles; National Institute on Minority Health... and other collaboratorsRecruiting
-
Italian Institute of TelemedicineItalian Society of Hypertension; Italian Society of General Practitioners; Biotechmed...Recruiting
-
Italian Institute of TelemedicineBPLabCompletedHypertensionRussian Federation, Argentina, Armenia, Australia, Italy, Kazakhstan, Mexico, Portugal, Romania, Ukraine
-
University of AarhusCompleted
-
General Administration of Military Health, TunisiaRecruiting
-
Yokohama City University Medical CenterCompletedDiabetes Mellitus | Renal Failure | Essential Hypertension | Chronic NephropathyJapan
-
Consorci d'Atenció Primària de Salut de l'EixampleInstituto de Salud Carlos IIICompleted
-
Seoul National University HospitalKangbuk Samsung Hospital; Severance Hospital; Eulji General HospitalUnknownHypertension | Chronic Kidney Diseases | Renal Insufficiency, Chronic | AlbuminuriaKorea, Republic of
-
Arkansas Children's Hospital Research InstitutePediatric Pharmacology Research Units NetworkCompleted